Impact of Visceral Obesity on Structural and Functional Alterations of Gut Microbiota in Polycystic Ovary Syndrome (PCOS): A Pilot Study Using Metagenomic Analysis

References

• Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):321–336. doi:10.1097/AOG.0000000000002698
   PubMed Web of Science ®Google Scholar
• Qi X, Yun C, Sun L, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25(8):1225–1233. doi:10.1038/s41591-019-0509-0
   PubMed Web of Science ®Google Scholar
• Jobira B, Frank DN, Pyle L, et al. Obese adolescents with PCOS have altered biodiversity and relative abundance in gastrointestinal microbiota. J Clin Endocrinol Metab. 2020;105(6):e2134–e2144. doi:10.1210/clinem/dgz263
   PubMed Web of Science ®Google Scholar
• Torres PJ, Siakowska M, Banaszewska B, et al. Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism. J Clin Endocrinol Metab. 2018;103(4):1502–1511. doi:10.1210/jc.2017-02153
   PubMed Web of Science ®Google Scholar
• Chen F, Chen Z, Chen M, et al. Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients. NPJ Biofilms Microbiomes. 2021;7(1):60. doi:10.1038/s41522-021-00231-6
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang C, Shi Y, et al. Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome. Front Microbiol. 2017;8:324. doi:10.3389/fmicb.2017.00324
   PubMed Web of Science ®Google Scholar
• Barber TM, Dimitriadis GK, Andreou A, Franks S. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin Med. 2016;16(3):262–266. doi:10.7861/clinmedicine.16-3-262
   PubMed Web of Science ®Google Scholar
• Yang YL, Zhou WW, Wu S, et al. Intestinal flora is a key factor in insulin resistance and contributes to the development of polycystic ovary syndrome. Endocrinology. 2021;162(10):bqab118. doi:10.1210/endocr/bqab118
   PubMed Web of Science ®Google Scholar
• Torres PJ, Ho BS, Arroyo P, et al. Exposure to a healthy gut microbiome protects against reproductive and metabolic dysregulation in a PCOS mouse model. Endocrinology. 2019;160(5):1193–1204. doi:10.1210/en.2019-00050
   PubMed Web of Science ®Google Scholar
• Shi W, Zhao Q, Zhao X, Xing C, He B. Analysis of endocrine and metabolic indexes in non-obese patients with polycystic ovary syndrome and its compare with obese patients. Diabetes Metab Syndr Obes. 2021;14:4275–4281. doi:10.2147/DMSO.S329108
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108–120. doi:10.1016/j.metabol.2018.11.002
   PubMed Web of Science ®Google Scholar
• Insenser M, Murri M, Del Campo R, et al. Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity. J Clin Endocrinol Metab. 2018;103(7):2552–2562.
   PubMed Web of Science ®Google Scholar
• Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404. doi:10.1152/physrev.00033.2011
   PubMed Web of Science ®Google Scholar
• Endocrinology and Metabolism Branch of Chinese Medical Doctor Association. Expert consensus on diagnosis and treatment of polycystic ovary syndrome. Chin J Endocrinol Metab. 2018;34(1):7.
   Google Scholar
• Examination Committee of Criteria for ‘Obesity Disease’ in Japan; Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66(11):987–992. doi:10.1253/circj.66.987
   PubMed Web of Science ®Google Scholar
• Bharti R, Grimm DG. Current challenges and best-practice protocols for microbiome analysis. Brief Bioinform. 2021;22(1):178–193. doi:10.1093/bib/bbz155
   PubMed Web of Science ®Google Scholar
• Mammadova G, Ozkul C, Yilmaz Isikhan S, Acikgoz A, Yildiz BO. Characterization of gut microbiota in polycystic ovary syndrome: findings from a lean population. Eur J Clin Invest. 2021;51(4):e13417. doi:10.1111/eci.13417
   PubMed Web of Science ®Google Scholar
• Tett A, Pasolli E, Masetti G, Ercolini D, Segata N. Prevotella diversity, niches and interactions with the human host. Nat Rev Microbiol. 2021;19(9):585–599. doi:10.1038/s41579-021-00559-y
   PubMed Web of Science ®Google Scholar
• Jobira B, Frank DN, Silveira LJ, et al. Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome. PLoS One. 2021;16(1):e0245219. doi:10.1371/journal.pone.0245219
   PubMed Web of Science ®Google Scholar
• Serena C, Ceperuelo-Mallafré V, Keiran N, et al. Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. ISME J. 2018;12(7):1642–1657. doi:10.1038/s41396-018-0068-2
   PubMed Web of Science ®Google Scholar
• Naderpoor N, Mousa A, Gomez-Arango LF, Barrett HL, Dekker Nitert M, de Courten B. Faecal microbiota are related to insulin sensitivity and secretion in overweight or obese adults. J Clin Med. 2019;8(4):452. doi:10.3390/jcm8040452
   PubMed Web of Science ®Google Scholar
• Pinart M, Dötsch A, Schlicht K, et al. Gut microbiome composition in obese and non-obese persons: a systematic review and meta-analysis. Nutrients. 2021;14(1):12. doi:10.3390/nu14010012
   PubMed Web of Science ®Google Scholar
• Moreno-Indias I, Sánchez-Alcoholado L, García-Fuentes E, Cardona F, Queipo-Ortuño MI, Tinahones FJ. Insulin resistance is associated with specific gut microbiota in appendix samples from morbidly obese patients. Am J Transl Res. 2016;8(12):5672–5684.
   PubMed Web of Science ®Google Scholar
• Wade WG. Dialister. Bergey’s manual of systematics of archaea and bacteria 2015. Available from: doi:10.1002/9781118960608.gbm00696. Accessed April 1, 2019.
   Google Scholar
• Cox TO, Lundgren P, Nath K, Thaiss CA. Metabolic control by the microbiome. Genome Med. 2022;14(1):80. doi:10.1186/s13073-022-01092-0
   PubMed Web of Science ®Google Scholar
• Nagao-Kitamoto H, Leslie JL, Kitamoto S, et al. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota. Nat Med. 2020;26(4):608–617. doi:10.1038/s41591-020-0764-0
   PubMed Web of Science ®Google Scholar
• Fan S, Raychaudhuri S, Page R, Shahinozzaman M, Obanda DN. Metagenomic insights into the effects of urtica dioica vegetable on the gut microbiota of C57BL/6J obese mice, particularly the composition of Clostridia. J Nutr Biochem. 2021;91:108594. doi:10.1016/j.jnutbio.2021.108594
   PubMed Web of Science ®Google Scholar
• Obanda DN, Husseneder C, Raggio AM, et al. Nutrition. Abundance of the species Clostridium butyricum in the gut microbiota contributes to differences in obesity phenotype in outbred Sprague-Dawley CD rats. Nutrition. 2020;78:110893. doi:10.1016/j.nut.2020.110893
   PubMedGoogle Scholar
• Zhao H, Chen R, Zheng D, et al. Modified banxia xiexin decoction ameliorates polycystic ovarian syndrome with insulin resistance by regulating intestinal microbiota. Front Cell Infect Microbiol. 2022;12:854796. doi:10.3389/fcimb.2022.854796
   PubMed Web of Science ®Google Scholar
• Debédat J, Clément K, Aron-Wisnewsky J. Gut microbiota dysbiosis in human obesity: impact of bariatric surgery. Curr Obes Rep. 2019;8(3):229–242. doi:10.1007/s13679-019-00351-3
   PubMed Web of Science ®Google Scholar
• Ghosh S, Dent R, Harper ME, Gorman SA, Stuart JS, McPherson R. Gene expression profiling in whole blood identifies distinct biological pathways associated with obesity. BMC Med Genomics. 2010;3:56. doi:10.1186/1755-8794-3-56
   PubMed Web of Science ®Google Scholar
• Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS. Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance. Cancer Res. 2022;82(13):2344–2353. doi:10.1158/0008-5472.CAN-21-4087
   PubMed Web of Science ®Google Scholar
• Wu J, Jiang X, Li Y, et al. PHA-4/FoxA senses nucleolar stress to regulate lipid accumulation in Caenorhabditis elegans. Nat Commun. 2018;9(1):1195. doi:10.1038/s41467-018-03531-2
   PubMedGoogle Scholar
• Bellini L, Campana M, Mahfouz R, et al. Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes. Expert Opin Ther Targets. 2015;19(8):1037–1050. doi:10.1517/14728222.2015.1028359
   PubMed Web of Science ®Google Scholar
• Parveen F, Bender D, Law SH, Mishra VK, Chen CC, Ke LY. Role of ceramidases in sphingolipid metabolism and human diseases. Cells. 2019;8(12):1573. doi:10.3390/cells8121573
   PubMed Web of Science ®Google Scholar